Functional neuroimaging (ECD/SPECT and 1.5 T MRI) in the differential diagnosis between MSA and Parkinson's disease (PD)

A. Antonini, R. Benti, A. Righini, M. Canesi, A. Zecchinelli, S. Tesei, C. Mariani, G. Pezzoli

Research output: Contribution to journalArticle

Abstract

Neuropathological studies have shown that approximately 20% of patients diagnosed in life with PD may prove at post-mortem to have MSA. PET studies have shown that a distinctive pattern of striatal receptor and glucose metabolism is associated with MSA. However, studies with SPECT may afford greater diffusion and practicability than PET. Analogously, MRI could provide complementary information in the differential diagnosis. Methods: We have performed ECD/SPECT and 1.5 T MRI scans in 30 patients with probable PD (H&Y II-IV; age 60±9) and 24 patients presenting with possible or probable MSA (H&Y II-IV; age 59±8). ECD/SPECT regions of interest were determined in the caudate nucleus, lentiform and the thalamus. For MRI we evaluated the presence of putaminal T2 hypointensity relative to globus pallidus and of a hyperintense band in the lateral putamen on proton density images. Sensitivity and specificity in detecting MSA vs. PD were then calculated for each technique. Results: For ECD/SPECT we found that perfusion values in the putamen significantly discriminated between MSA and PD (F = 15.5; p <0.0001). Specificity was 100% and sensitivity 88% to correctly identify MSA. For MRI the hyperintense band in the lateral had a specificity of 100% and a sensitivity of 83%. By contrast, the putaminal T2 hypointensity had a specificity of 84% and a sensitivity of 83%. Overall both investigations gave a positive predictive value of 100%. Conclusion: Both ECD/SPECT and MRI scanning afford high sensitivity and specificity and their combination represents a useful adjunct to clinical evaluation in supporting the diagnosis of possible or probable MSA. MRI and SPECT perfusion changes in the basal ganglia are suggestive of degeneration of striatal projection neurons in those individuals.

Original languageEnglish
Pages (from-to)269
Number of pages1
JournalItalian Journal of Neurological Sciences
Volume20
Issue number4
Publication statusPublished - 1999

Fingerprint

Functional Neuroimaging
Single-Photon Emission-Computed Tomography
Parkinson Disease
Differential Diagnosis
Corpus Striatum
Putamen
Perfusion
Sensitivity and Specificity
Globus Pallidus
Caudate Nucleus
Basal Ganglia
Thalamus
Protons
Magnetic Resonance Imaging
Neurons

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Functional neuroimaging (ECD/SPECT and 1.5 T MRI) in the differential diagnosis between MSA and Parkinson's disease (PD). / Antonini, A.; Benti, R.; Righini, A.; Canesi, M.; Zecchinelli, A.; Tesei, S.; Mariani, C.; Pezzoli, G.

In: Italian Journal of Neurological Sciences, Vol. 20, No. 4, 1999, p. 269.

Research output: Contribution to journalArticle

Antonini, A, Benti, R, Righini, A, Canesi, M, Zecchinelli, A, Tesei, S, Mariani, C & Pezzoli, G 1999, 'Functional neuroimaging (ECD/SPECT and 1.5 T MRI) in the differential diagnosis between MSA and Parkinson's disease (PD)', Italian Journal of Neurological Sciences, vol. 20, no. 4, pp. 269.
Antonini, A. ; Benti, R. ; Righini, A. ; Canesi, M. ; Zecchinelli, A. ; Tesei, S. ; Mariani, C. ; Pezzoli, G. / Functional neuroimaging (ECD/SPECT and 1.5 T MRI) in the differential diagnosis between MSA and Parkinson's disease (PD). In: Italian Journal of Neurological Sciences. 1999 ; Vol. 20, No. 4. pp. 269.
@article{6a0d12b8f3f146a88deed5054833355c,
title = "Functional neuroimaging (ECD/SPECT and 1.5 T MRI) in the differential diagnosis between MSA and Parkinson's disease (PD)",
abstract = "Neuropathological studies have shown that approximately 20{\%} of patients diagnosed in life with PD may prove at post-mortem to have MSA. PET studies have shown that a distinctive pattern of striatal receptor and glucose metabolism is associated with MSA. However, studies with SPECT may afford greater diffusion and practicability than PET. Analogously, MRI could provide complementary information in the differential diagnosis. Methods: We have performed ECD/SPECT and 1.5 T MRI scans in 30 patients with probable PD (H&Y II-IV; age 60±9) and 24 patients presenting with possible or probable MSA (H&Y II-IV; age 59±8). ECD/SPECT regions of interest were determined in the caudate nucleus, lentiform and the thalamus. For MRI we evaluated the presence of putaminal T2 hypointensity relative to globus pallidus and of a hyperintense band in the lateral putamen on proton density images. Sensitivity and specificity in detecting MSA vs. PD were then calculated for each technique. Results: For ECD/SPECT we found that perfusion values in the putamen significantly discriminated between MSA and PD (F = 15.5; p <0.0001). Specificity was 100{\%} and sensitivity 88{\%} to correctly identify MSA. For MRI the hyperintense band in the lateral had a specificity of 100{\%} and a sensitivity of 83{\%}. By contrast, the putaminal T2 hypointensity had a specificity of 84{\%} and a sensitivity of 83{\%}. Overall both investigations gave a positive predictive value of 100{\%}. Conclusion: Both ECD/SPECT and MRI scanning afford high sensitivity and specificity and their combination represents a useful adjunct to clinical evaluation in supporting the diagnosis of possible or probable MSA. MRI and SPECT perfusion changes in the basal ganglia are suggestive of degeneration of striatal projection neurons in those individuals.",
author = "A. Antonini and R. Benti and A. Righini and M. Canesi and A. Zecchinelli and S. Tesei and C. Mariani and G. Pezzoli",
year = "1999",
language = "English",
volume = "20",
pages = "269",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Functional neuroimaging (ECD/SPECT and 1.5 T MRI) in the differential diagnosis between MSA and Parkinson's disease (PD)

AU - Antonini, A.

AU - Benti, R.

AU - Righini, A.

AU - Canesi, M.

AU - Zecchinelli, A.

AU - Tesei, S.

AU - Mariani, C.

AU - Pezzoli, G.

PY - 1999

Y1 - 1999

N2 - Neuropathological studies have shown that approximately 20% of patients diagnosed in life with PD may prove at post-mortem to have MSA. PET studies have shown that a distinctive pattern of striatal receptor and glucose metabolism is associated with MSA. However, studies with SPECT may afford greater diffusion and practicability than PET. Analogously, MRI could provide complementary information in the differential diagnosis. Methods: We have performed ECD/SPECT and 1.5 T MRI scans in 30 patients with probable PD (H&Y II-IV; age 60±9) and 24 patients presenting with possible or probable MSA (H&Y II-IV; age 59±8). ECD/SPECT regions of interest were determined in the caudate nucleus, lentiform and the thalamus. For MRI we evaluated the presence of putaminal T2 hypointensity relative to globus pallidus and of a hyperintense band in the lateral putamen on proton density images. Sensitivity and specificity in detecting MSA vs. PD were then calculated for each technique. Results: For ECD/SPECT we found that perfusion values in the putamen significantly discriminated between MSA and PD (F = 15.5; p <0.0001). Specificity was 100% and sensitivity 88% to correctly identify MSA. For MRI the hyperintense band in the lateral had a specificity of 100% and a sensitivity of 83%. By contrast, the putaminal T2 hypointensity had a specificity of 84% and a sensitivity of 83%. Overall both investigations gave a positive predictive value of 100%. Conclusion: Both ECD/SPECT and MRI scanning afford high sensitivity and specificity and their combination represents a useful adjunct to clinical evaluation in supporting the diagnosis of possible or probable MSA. MRI and SPECT perfusion changes in the basal ganglia are suggestive of degeneration of striatal projection neurons in those individuals.

AB - Neuropathological studies have shown that approximately 20% of patients diagnosed in life with PD may prove at post-mortem to have MSA. PET studies have shown that a distinctive pattern of striatal receptor and glucose metabolism is associated with MSA. However, studies with SPECT may afford greater diffusion and practicability than PET. Analogously, MRI could provide complementary information in the differential diagnosis. Methods: We have performed ECD/SPECT and 1.5 T MRI scans in 30 patients with probable PD (H&Y II-IV; age 60±9) and 24 patients presenting with possible or probable MSA (H&Y II-IV; age 59±8). ECD/SPECT regions of interest were determined in the caudate nucleus, lentiform and the thalamus. For MRI we evaluated the presence of putaminal T2 hypointensity relative to globus pallidus and of a hyperintense band in the lateral putamen on proton density images. Sensitivity and specificity in detecting MSA vs. PD were then calculated for each technique. Results: For ECD/SPECT we found that perfusion values in the putamen significantly discriminated between MSA and PD (F = 15.5; p <0.0001). Specificity was 100% and sensitivity 88% to correctly identify MSA. For MRI the hyperintense band in the lateral had a specificity of 100% and a sensitivity of 83%. By contrast, the putaminal T2 hypointensity had a specificity of 84% and a sensitivity of 83%. Overall both investigations gave a positive predictive value of 100%. Conclusion: Both ECD/SPECT and MRI scanning afford high sensitivity and specificity and their combination represents a useful adjunct to clinical evaluation in supporting the diagnosis of possible or probable MSA. MRI and SPECT perfusion changes in the basal ganglia are suggestive of degeneration of striatal projection neurons in those individuals.

UR - http://www.scopus.com/inward/record.url?scp=33746325816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746325816&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746325816

VL - 20

SP - 269

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -